Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway
Launch of CARDAMYST® (etripamil) nasal spray marked by steady prescription growth, new prescriber ex
Launch of CARDAMYST® (etripamil) nasal spray marked by steady prescription growth, new prescriber ex